Greener Pastures? Long-Time Pfizer China GM Starts New Era
15 year-serving Pfizer China GM Wu Xiaobing and AstraZeneca China's Senior VP for biologics Shoubai Chao are the latest to jump on board China's booming biotech boat, are there more to come?
You may also be interested in...
The coming of June has brought new executives at Daiichi Sankyo, UCB, ViiV in Japan and ZAI Lab in China.
China has shown willingness to go tit-for-tat in its bilateral disputes with the US and the latest comments from US officials show an underlying distrust over clinical data and vaccines safety in China, raising fresh concerns just when collaboration is needed to accelerate availability of the first vaccines in the global pandemic.
As the largest manufacturer of active pharmaceutical ingredients globally, China is bracing for more uncertainty amid the global pandemic and fast-changing environment, particularly in the US.